Inhibition of angiogenesis in liver metastases by carboxyamidotriazole (CAI)

Abstract
Carboxyamidotriazole (CAI), an inhibitor of calcium-mediated signal transduction, is a promising new cytostatic anti-cancer drug which has entered Phase II clinical trials, and for which multiple...

This publication has 0 references indexed in Scilit: